Ildong Bioscience Highlights Postbiotics Competitiveness at Vitafoods Asia

Introducing "PPP Probiotics"
Containing Prebiotics, Probiotics, and Postbiotics

Ildong Bioscience, a health functional food company under Ildong Pharmaceutical Group, announced on the 22nd that it participated in the 2025 Vitafoods Asia to explore business opportunities.

Ildong Bioscience, a health functional food specialist company under Ildong Pharmaceutical Group, is participating in the 2025 Vitafoods Asia and welcoming visitors at its booth. Ildong Pharmaceutical

Vitafoods Asia is the largest healthcare food exhibition in the Asia-Pacific region, and this year's event was held in Bangkok, Thailand, from September 17 to 19.

During the event, Ildong Bioscience highlighted its business competitiveness in the probiotics sector by showcasing a variety of functional ingredients and products, as well as its quadruple coating processing technology. The company also sought to expand its presence in the Asian market by identifying potential collaborators and holding partnering meetings.

The company explained that at this event, it received positive feedback for presenting its "PPP Probiotics" product, which contains not only probiotics-live microorganisms that provide health benefits when consumed-but also prebiotics and postbiotics, both of which are closely related to probiotics.

Prebiotics are substances that help promote the growth and activation of beneficial microorganisms in the gut, while postbiotics refer to the beneficial metabolic byproducts produced by probiotics such as lactic acid bacteria.

According to Ildong Bioscience, "PPP Probiotics" stands out by combining raw materials from three categories-prebiotics, probiotics, and postbiotics-into a single product, offering both functional benefits and convenience of consumption.

In addition to business promotion activities, Ildong Bioscience also participated in a seminar organized by the Korea Health Functional Food Association at the exhibition, where it introduced its research achievements and commercialization technologies related to postbiotics for functional gastrointestinal disorders.

Since 2022, Ildong Bioscience has partnered with a healthcare distributor in Thailand to supply probiotic ingredients and semi-finished products, and is now seeking to expand its business to include finished product supply and ODM (Original Design Manufacturing).

A representative from Ildong Bioscience stated, "We plan to develop products suitable for the Asian and global markets and diversify our marketing strategies by utilizing our functional probiotics and postbiotics, including over 20 ingredients certified as GRAS (Generally Recognized As Safe) in the United States."

This content was produced with the assistance of AI translation services.